Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Taljaard

Showing results (21-30 of 525) with videos related to

Pageof 53
Sort By:
Statistics in Medicine|July 20, 2019
Information content of stepped-wedge designs when treatment effect heterogeneity and/or implementation periods are presentJessica Kasza, Monica Taljaard, Andrew B Forbes
American Journal of Public Health|January 14, 2026
Myran et al. RespondDaniel T Myran, Rosalie Pacula, Monica Taljaard
Clinical Trials (London, England)|March 3, 2016
Cluster-randomized trials: A closer lookAndrew D McRae, Monica Taljaard, Charles Weijer
Ethics & Human Research|November 2, 2020
Loopholes in the Research Ethics System? Informed Consent Waivers in Cluster Randomized Trials with Individual-Level InterventionAlex John London, Monica Taljaard, Charles Weijer
The American Journal of Bioethics : AJOB|January 8, 2020
The Importance of Describing as Well as Defining Usual CareStuart G Nicholls, Merrick Zwarenstein, Monica Taljaard
Clinical Trials (London, England)|December 19, 2017
TwiC or treat? Are trials within cohorts ethically defensible?Charles Weijer, Cory E Goldstein, Monica Taljaard
Statistics in Medicine|December 24, 2022
Power analyses for stepped wedge designs with multivariate continuous outcomesKendra Davis-Plourde, Monica Taljaard, Fan Li
Biometrics|October 31, 2021
Sample size considerations for stepped wedge designs with subclustersKendra Davis-Plourde, Monica Taljaard, Fan Li
The Medical Journal of Australia|February 15, 2019
The stepped wedge cluster randomised trial: what it is and when it should be usedMichael J Campbell, Karla Hemming, Monica Taljaard
Clinical Trials (London, England)|October 16, 2024
Are pragmatism and ethical protections in clinical trials a zero-sum game?Hayden P Nix, Charles Weijer, Monica Taljaard
Pageof 53

Showing results (21-30 of 525) with videos related to

Sort By:
Pageof 53
Statistics in Medicine|July 20, 2019
Information content of stepped-wedge designs when treatment effect heterogeneity and/or implementation periods are presentJessica Kasza, Monica Taljaard, Andrew B Forbes
American Journal of Public Health|January 14, 2026
Myran et al. RespondDaniel T Myran, Rosalie Pacula, Monica Taljaard
Clinical Trials (London, England)|March 3, 2016
Cluster-randomized trials: A closer lookAndrew D McRae, Monica Taljaard, Charles Weijer
Ethics & Human Research|November 2, 2020
Loopholes in the Research Ethics System? Informed Consent Waivers in Cluster Randomized Trials with Individual-Level InterventionAlex John London, Monica Taljaard, Charles Weijer
The American Journal of Bioethics : AJOB|January 8, 2020
The Importance of Describing as Well as Defining Usual CareStuart G Nicholls, Merrick Zwarenstein, Monica Taljaard
Clinical Trials (London, England)|December 19, 2017
TwiC or treat? Are trials within cohorts ethically defensible?Charles Weijer, Cory E Goldstein, Monica Taljaard
Statistics in Medicine|December 24, 2022
Power analyses for stepped wedge designs with multivariate continuous outcomesKendra Davis-Plourde, Monica Taljaard, Fan Li
Biometrics|October 31, 2021
Sample size considerations for stepped wedge designs with subclustersKendra Davis-Plourde, Monica Taljaard, Fan Li
The Medical Journal of Australia|February 15, 2019
The stepped wedge cluster randomised trial: what it is and when it should be usedMichael J Campbell, Karla Hemming, Monica Taljaard
Clinical Trials (London, England)|October 16, 2024
Are pragmatism and ethical protections in clinical trials a zero-sum game?Hayden P Nix, Charles Weijer, Monica Taljaard
Pageof 53